Biotechnology giant Amgen today pleaded guilty in federal court to a misdemeanor charge of misbranding Aranesp (darbepoetin alfa), its highly successful anemia drug.
Edward Valencia, 51, Federico Valencia, 58, and Rose Marie Cuellar, 20, were arrested on misdemeanor charges of misbranding a drug in violation of the federal Food, Drug, and Cosmetic Act.